Kromek Group PLC (KMK)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 5.600 |
|---|---|
| 52-week range | 5.400 – 13.000 |
| Return, 1 month / 3 months | −13.8% / −30.0% |
| Return, 1 year / 3 years | −25.3% / +21.7% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 62.3% |
| Worst drawdown (1 year) | -57.0% |
| Average daily value traded | 10.00M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kromek Group makes radiation detection components and systems, drawing on cadmium zinc telluride and other sensor materials. Its products serve medical imaging, where its detectors help scanners produce clearer pictures, security and counter-terrorism screening at airports and borders, and nuclear safety and monitoring. Customers include equipment makers, government agencies and healthcare organisations. The company is based in County Durham in the north east of England, with additional operations in the United States.
Kromek Group PLC trades under the code KMK on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kromek Group PLC (KMK) trades on the London Stock Exchange in UK. It last closed at GBX 5.600 on 27 October 2026.
Its price-based Market X-Ray is 22 out of 100 (a weak price profile), ranking 3,362 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 25.3% and over the last three months it fell 30.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 7 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -37.7% | ||
| From 52-week high | -55.4% | ||
| Momentum | 12 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -30.0% | ||
| 6-month return | -50.0% | ||
| 12-month return, skipping the last month | -13.3% | ||
| Stability (higher is calmer) | 16 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 62.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.0% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 10.00M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −13.8% |
| 3 months | −30.0% |
| 6 months | −50.0% |
| 1 year | −25.3% |
| 3 years | +21.7% |
| 5 years | −65.8% |
Signals
| 50-day / 200-day average | 6.718 / 8.984 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.337 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.